FetalFirst Registers Clinical Trial to Validate AI-Based Neonatal Risk Prediction
FetalFirst’s clinical trial “AI-Powered Neonatal Risk Assessment for Improved Perinatal Outcomes” is now officially registered on ClinicalTrials.gov (NCT07064356), marking a major milestone in our mission to deliver AI-driven diagnostics and support for high-risk pregnancies.
FetalFirst Joins NVIDIA Inception to Advance GPU-Powered Prenatal Diagnostics
FetalFirst has been accepted into NVIDIA Inception, marking a major milestone in our mission to transform fetal medicine. This strategic step gives us access to cutting-edge AI development resources, helping us scale our prenatal diagnostic platform globally.
FetalFirst Achieves NHS Research Ethics Committee Approval for Breakthrough AI Neonatal Risk Assessment Platform
Breaking News: FetalFirst Achieves NHS Research Ethics Committee Approval
First comprehensive GPU -powered AI platform authorised for clinical validation in UK healthcare system
June 24, 2025 — FetalFirst receives full ethical approval from Wales Research Ethics Committee for landmark AI-powered neonatal risk assessment study, marking critical regulatory milestone for maternal-fetal medicine innovation.